Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Better Therapeutics, Inc. - Common Stock
(NQ:
BTTX
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Mar 15, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
0.0360 (500)
Ask (Size)
0.0370 (3)
Prev. Close
0.0446
Today's Range
N/A - N/A
52wk Range
N/A - N/A
Shares Outstanding
31,731,352
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
12 Health Care Stocks Moving In Friday's After-Market Session
↗
March 15, 2024
Via
Benzinga
Why Jabil Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Friday's Mid-Day Session
↗
March 15, 2024
Shares of Jabil Inc. (NYSE: JBL) fell sharply during Friday’s session after the company reported financial second-quarter results and issued FY25 guidance below estimates.
Via
Benzinga
Performance
More News
Read More
12 Health Care Stocks Moving In Friday's Intraday Session
↗
March 15, 2024
Via
Benzinga
Nasdaq Down Over 100 Points; Hibbett Reports Downbeat Sales
↗
March 15, 2024
Via
Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
March 15, 2024
Via
Benzinga
Why Cardlytics Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket
↗
March 15, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
↗
March 15, 2024
Via
InvestorPlace
Dow Dips Over 100 Points; Dick's Sporting Goods Earnings Top Views
↗
March 14, 2024
Via
Benzinga
Topics
Stocks
Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
March 14, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
March 14, 2024
Via
Benzinga
Crude Oil Moves Higher; Dollar General Posts Upbeat Earnings
↗
March 14, 2024
Via
Benzinga
Topics
Stocks
Better Therapeutics Announces it will Seek Strategic Alternatives and will be Delisted from Nasdaq
March 14, 2024
From
Better Therapeutics, Inc.
Via
Business Wire
Better Therapeutics Announces an Innovative Partnership with the American College of Lifestyle Medicine to Expand Access to AspyreRx Across 1,400 Federally Qualified Health Centers
March 05, 2024
From
Better Therapeutics, Inc.
Via
Business Wire
Better Therapeutics Announces Acceptance of Late Breaking Abstract for Its AspyreRx Pivotal Trial 180 Day Outcomes and Participation at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)
March 04, 2024
From
Better Therapeutics, Inc.
Via
Business Wire
Better Therapeutics Follows Up Wins Including FDA Authorization For AspyreRx In 2023 With Securing FDA Breakthrough Device Designation Targeting Advanced Liver Disease
February 26, 2024
Via
News Direct
Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
February 20, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
February 20, 2024
Via
Benzinga
Better Therapeutics Receives FDA Breakthrough Device Designation for Digital Therapeutic Platform Targeting Advanced Liver Disease
February 20, 2024
From
Better Therapeutics, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
↗
February 12, 2024
Via
Benzinga
Better Therapeutics Signs Rebate Agreement with One of the Largest Pharmacy Benefit Managers in the US for its AspyreRx Diabetes Treatment
February 06, 2024
From
Better Therapeutics Inc.
Via
Business Wire
Better Therapeutics Announces Publication of Cost-Effectiveness Analysis Demonstrating AspyreRx is More Effective and Less Costly than Standard of Care Alone
January 17, 2024
From
Better Therapeutics Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
January 11, 2024
Via
Benzinga
Better Therapeutics and Glooko Announce Partnership to Accelerate Adoption of AspyreRx to Treat Type 2 Diabetes in the United States
January 04, 2024
From
Better Therapeutics
Via
Business Wire
Why LumiraDx Shares Are Trading Lower By 20%; Here Are 20 Stocks Moving Premarket
↗
January 02, 2024
Via
Benzinga
Better Therapeutics Announces Submission for FDA Breakthrough Device Designation for Digital Therapeutic Platform to Treat Liver Disease
January 02, 2024
From
Better Therapeutics, Inc.
Via
Business Wire
Frequently Asked Questions
Is Better Therapeutics, Inc. - Common Stock publicly traded?
Yes, Better Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Better Therapeutics, Inc. - Common Stock trade on?
Better Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Better Therapeutics, Inc. - Common Stock?
The ticker symbol for Better Therapeutics, Inc. - Common Stock is BTTX on the Nasdaq Stock Market
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today